Literature DB >> 3961192

Safer, more expensive iodinated contrast agents: how do we decide?

G L Wolf.   

Abstract

The advantages of the new, safer, but more expensive iodinated contrast agents are discussed, and opinions on which patient groups should receive the agents are presented.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3961192     DOI： 10.1148/radiology.159.2.3961192

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  5 in total

1.  Nonionic contrast media: economic analysis and health policy development.

Authors:  V Goel; R B Deber; A S Detsky
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

Review 2.  Should nonionic radiographic contrast media be given to all patients?

Authors:  P S Parfrey; B C Cramer; P J McManamon
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262

3.  Comparison of Hexabrix 320 and Hexabrix 250 in aortoperipheral arteriography: towards cheaper low osmolar contrast media?

Authors:  P F Joyce; M O'Neill; E Kweka; Q M Bajwa
Journal:  Cardiovasc Intervent Radiol       Date:  1989 May-Jun       Impact factor: 2.740

4.  Hemodynamic effects of high versus low-osmolar contrast media for ventriculography in severe aortic stenosis.

Authors:  C R Lambert; C J Pepine
Journal:  Cardiovasc Intervent Radiol       Date:  1988       Impact factor: 2.740

5.  Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging.

Authors:  J F Debatin; S N Nadel; L Gray; H S Friedman; P Trotter; B Hockenberger; W J Oakes
Journal:  Pediatr Radiol       Date:  1992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.